Craig E. Fraser
Board Member
Windtree Therapeutics Inc /De/ (WINT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Craig E. Fraser
Craig E. Fraser is recorded as Board Member and Chairman at Windtree Therapeutics Inc /De/ (WINT). Windtree Therapeutics Inc /De/ reported in an 8-K filed April 18, 2025 that Craig E. Fraser resigned as Board of Directors, effective April 17, 2025. Windtree Therapeutics Inc /De/ reported in an 8-K filed November 14, 2024 that Craig E. Fraser retired as President and Chief Executive Officer, effective December 1, 2024. Windtree Therapeutics Inc /De/ reported in an 8-K filed August 16, 2023 that Craig E. Fraser was appointed Director, effective August 15, 2023. Equibles holds 4 filed executive changes naming Craig E. Fraser; each is listed under recent activity with its source filing. The proxy statement of Windtree Therapeutics Inc /De/ reports total compensation of $693,625 for Craig E. Fraser in fiscal 2023, including a base salary of $557,300. Disclosed compensation is on record for 5 fiscal years.
“On April 17, 2025, Mr. Fraser notified the Windtree Therapeutics, Inc.(the "Company") Board of Directors (the "Board") of his resignation from the Board, effective immediately.”
“On November 14, 2024, Windtree Therapeutics, Inc. (the “Company”) announced that Craig Fraser will retire as the Company’s President and Chief Executive Officer, effective as of December 1, 2024 (the “Transition Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-15–present
-
Current
2023-06-22–present
-
2023-08-15–2025-04-17
-
Start not stated–2024-12-01
-
Start not stated–2025-04-17
-
Start not stated–2024-12-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Windtree Therapeutics Inc /De/
Other people whose current roles at this company are on record from its filings.
- Jed Latkin CEO, Board Member
- Former Senior VP CFO
- Jamie McAndrew CFO, Chief Accounting Officer
- John Tattory CFO
- Senior VP CFO
- Diane Carman General Counsel
- Andrew Kucharchuk Board Member
- Daniel Geffken Board Member
- Dr. Evan Loh Board Member
- Dr. Robert Scott Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Windtree Therapeutics Inc /De/ (WINT) | President and CEO | $557,300 | $693,625 |
| 2022 | Windtree Therapeutics Inc /De/ (WINT) | President and CEO | $544,600 | $940,910 |
| 2021 | Windtree Therapeutics Inc /De/ (WINT) | President and CEO | $479,931 | $1,877,162 |
| 2020 | Windtree Therapeutics Inc /De/ (WINT) | President and CEO | $460,284 | $769,963 |
| 2019 | Windtree Therapeutics Inc /De/ (WINT) | President and Chief Executive Officer | $452,381 | $1,063,644 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.